GSK shares jump on $2.2 billion Zantac settlement
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...
FierceBiotech12h
Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...
San Diego Reader6h
Novo Brazil puts is kombucha to good use in cocktail
Not only did I not know that longtime local brewery Novo Brazil had opened a new spot in the Mission Valley Mall, but I also ...
Human Insulin Market to Hit USD 24.6 Billion by 2032, Fueled by Rising Diabetes Cases and Innovation – SNS Insider
According to Research by SNS Insider, The Human Insulin Market is projected to grow at a CAGR of 3.4%, fueled by regulatory reforms and the launch of biosimilars.Pune, Oct. 10, 2024 (GLOBE NEWSWIRE) - ...
Type 1 Diabetes Market Set To Eyewitness Substantial Growth By 2024-2031: Sanofi, Wockhardt Ltd., Ypsomed AG, Novartis
Type 1 Diabetes Market Set To Eyewitness Substantial Growth By 2024-2031: Sanofi, Wockhardt Ltd., Ypsomed AG, Novartis Type 1 Diabetes Market is expected to reach USD 24.36 Bn by 2031, exhibiting a ...
Forbes11h
Convert Brazilian Real To United States Dollar
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.